{
  "id": 16906739,
  "title": "STAT+: Lilly’s triple-G drug beats Ozempic in head-to-head study",
  "url": "https://urgent.news/2026/10/28/stat-lillys-triple-g-drug-beats-ozempic-in-head-to-head-study",
  "topic": "science",
  "section": "Science",
  "published": "2026-10-28T13:42:44.000Z",
  "source": {
    "name": "STAT News",
    "slug": "stat-news",
    "url": "https://www.statnews.com/2026/10/28/biotech-news-lillys-triple-g-drug-beats-ozempic-in-head-to-head-study/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Eli Lilly announced that its investigational drug retatrutide was more effective at lowering blood sugar and cutting weight than Novo Nordisk’s Ozempic in a large diabetes study.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}